Long-term follow-up of patients with sleep apnea in Europe
Collection of Medical Events Occurring During Long-term Follow-up in Patients Included in the European Sleep Apnea Data Base (ESADA)
This study looks at how well CPAP treatment helps people with sleep apnea in Europe by tracking their health over time, including heart issues, cancer, and overall survival.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 500 (estimated) |
| Ages | 18 Years to 80 Years |
| Sex | All |
| Sponsor | University Hospital, Grenoble Academic / other |
| Locations | 1 site (Grenoble) |
| Trial ID | NCT04800341 on ClinicalTrials.gov |
What this trial studies
The ESADA project collects long-term follow-up data from over 30,000 patients with obstructive sleep apnea (OSA) across various European countries. This observational study aims to gather information on cardiovascular events, metabolic events, incident cancers, and mortality through structured questionnaires and telephone interviews. The data will be centralized at the coordinating center to assess the impact of continuous positive airway pressure (CPAP) treatment on these outcomes. The study leverages existing data from the ESADA database to enhance understanding of long-term patient outcomes.
Who should consider this trial
Good fit: Ideal candidates are individuals who have already been included in the ESADA European database.
Not a fit: Patients who refuse to participate in the follow-up will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve the management and treatment of sleep apnea by identifying long-term health risks and the effectiveness of CPAP therapy.
How similar studies have performed: Other studies utilizing large databases for long-term follow-up in sleep apnea have shown promising results, indicating that this approach is supported by previous successes.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * already included in the ESADA European database Exclusion Criteria: * refusal to participate
Where this trial is running
Grenoble
- University Hospital Grenoble — Grenoble, France (Recruiting)
Study contacts
- Principal investigator: Jean-Louis PEPIN, MD — University Hospital, Grenoble
- Study coordinator: Marie JOYEUX-FAURE, PharmD
- Email: mjoyeuxfaure@chu-grenoble.fr
- Phone: 476767166
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.